Malaria was once considered a terrible disease. But now, over time and with the advent of science, this is no longer the case. Death from malaria is rarely found today. Only a few cases develop complications, these are the cases that are not treated in the early stage of the disease.
The complication of hypoglycemia , malaria-associated renal failure has greatly reduced. Whenever a doctor prescribes quinine to the patient, he should make sure that the patient is not hypoglycemic and that regular monitoring is done. In case of hypoglycaemia, dextrose is administered intravenously immediately. With so many good techniques, the chances of death from malaria are almost negligible.
If a patient dies from malaria, the cause is mainly due to renal failure, where erythrocytes are sequestered in the renal tubules, interfering with renal microcirculation and metabolism, and may develop acute renal failure. If a patient with malaria develops anemia, the chances of death increase. This happens when erythrocytes are removed from circulation by the spleen. Anemia can sometimes be lethal. When a patient complains of hemoglobin level below 7 g. % is time for a transfusion. So with anemia come so many transfusion-related problems.
Malaria death is very rare today. Mostly death occurs from cerebral malaria, where blood vessels are blocked by erythrocytes and thus the blood supply is compromised.
This leads to brain problems. Cerebral malaria was once considered a serious problem, but due to good diagnostic and early screening facilities, the problem of cerebral malaria has been greatly reduced.
Malaria drugs are very reliable and resistance does not develop quickly. The dosage pattern with each age group changes and according to regime changes in all states. The states of northern India follow a different regime, while other states follow a different regime. Drug combinations are given to prevent resistance. New drugs, such as artemether, have revolutionized malaria management. Consequently, with the advent of these new drugs, the chances of death due to malaria have decreased dramatically. And it is expected that within a year, a malaria vaccine will be emerging. This vaccine is currently in the testing phase. Thus, the sooner the vaccine is introduced, the faster the turnover of malaria patients.
In addition to the vaccine, people are really very aware these days. Prevention methods against the malaria parasite and its vector are taken by most people around the world. The use of insecticides and mosquito nets is being used. Oil spraying in ditches after heavy rainfall is another common community-based method to prevent mosquito breeding. Several methods including space spray and residual sprays have been introduced. Typically, in many places, areas are sprayed with these sprays monthly to prevent mosquito survival.
In addition, knowledge about the disease is given to everyone, so they can consult a doctor if they find any signs of malaria. The disease occurs when there is a lack of awareness. Once a person becomes aware of the problem, it is difficult to get the disease. Malaria was once considered a serious health problem, but now many of us suffer from malaria and survive the disease. This shows that mortality is rapidly decreased due to disease.
If complications occur for malaria, the required time period would be one month, as complications do not develop within one night. These complications require almost a month to appear correctly. But fortunately, with so much progress in medical science, the infection is diagnosed early and there is less chance of death. Malaria should be treated early and if treated early, the disease can be completely corrected. Be alert and be aware.
- Malaria is contagious, do you know the incubation period, treatment and recovery period of malaria?
- How is malaria transmitted? | Malaria Treatment and Prevention
- Which countries have malaria?
- What should I eat when I am suffering from malaria?
- How can malaria kill you?
- Can malaria go away on its own?
- Can malaria come back after treatment?
Eu sou o Dr. Ruby Crowder e sou especialista em medicina pulmonar e cuidados intensivos. Eu me formei na Universidade da Califórnia, em San Francisco. Eu trabalho no Hospital Geral de São Francisco e Centro de Trauma de Zuckerberg. Eu também sou professor associado de medicina na Universidade da Califórnia, em San Francisco.
Eu pesquisei a epidemiologia e o manejo da tuberculose em países de alta incidência e publiquei muitos remédios e artigos relacionados à saúde sobre o Exenin e em outras revistas médicas.
Finalmente, gosto de viajar, mergulhar e andar de mochila.